A study led by the ITACA Institute of the Universitat Politècnica de València, with the participation of the Institut Català d’Oncologia (ICO), the Institut Investigació Germans Trias I Pujol (IGTP) and the Hospital Clinic de Barcelona, opens up a novel approach for improving personalized treatments for patients with glioblastoma, one of the most aggressive types of cancer in existence today.
Wes Streeting says patients should view data sharing ‘the same as taxes’ – Pharmaceutical Technology
Wes Streeting talking at the Jefferies London Healthcare Conference on 19 November. Image credit: Robert Barrie / GlobalData. UK Secretary of Health and Social Care